Clinico-microbiological profile of chronic pulmonary aspergillosis from a tertiary care centre in Southern India

Kiran Chawla, Kranthi Kosaraju, Sridevi Rayasam, Chiranjay Mukhopadhyay

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: Pulmonary aspergillosis is commonly seen in immunocompromised individuals. A significant rise has been seen in these cases in the past decade, owing to growing number of patients with impaired immune status. Aim: This study includes the detailed clinical and microbiological profiles of all the culture positive cases of pulmonary aspergillosis, detected in three years, from Jan 2008-Dec 2010, at our tertiary care centre. Methods: A hospital based observational and retrospective study was conducted to study the clinico-microbiological characteristics of patients with pulmonary aspergillosis. Respiratory specimens which showed repeated isolation of Aspergillus were included in the study. Demographic details, clinical findings and predisposing factors were noted down for all the patients. Treatment of patients with antifungal agents and their responses to treatment were also documented. Results: There were 22 patients with male to female ratio of 1.2:1 and mean age of 52.5 years. The most common underlying lung disease was presence of bronchial asthma in 27.3% (6/22) cases. Many patients (40.9%; 9/22) were on steroid treatment. Cough with expectoration was the most common symptom observed in 72.7% (16/22) cases. Microbiologically, microscopy showed positivity for the presence of gram positive, acutely branched, fungal hyphae, suggestive of Aspergillus, in all the cases. Aspergillus fumigatus was the predominant species that was isolated in 40.9% (9/22) cases. All the diagnosed patients were given either oral itraconazole or intravenous amphotericin B. A clinical improvement was observed in 72.5% (16/22) cases, but 27.3% (6/22) patients died. Conclusion: Pulmonary aspergillosis presents with non-specific clinical and radiological findings. An early suspicion and diagnosis is essential, especially in patients with underlying lung disease, to prevent dissemination and invasion.

Original languageEnglish
Pages (from-to)2712-2715
Number of pages4
JournalJournal of Clinical and Diagnostic Research
Volume7
Issue number12
DOIs
Publication statusPublished - 15-12-2013

Fingerprint

Pulmonary Aspergillosis
Aspergillus
Tertiary Care Centers
India
Pulmonary diseases
Itraconazole
Antifungal Agents
Amphotericin B
Microscopic examination
Steroids
Lung Diseases
Aspergillus fumigatus
Hyphae
Cough
Causality
Observational Studies
Early Diagnosis
Microscopy
Therapeutics
Asthma

All Science Journal Classification (ASJC) codes

  • Clinical Biochemistry

Cite this

@article{307b0bcc4b634a118e295d0950c9b7ac,
title = "Clinico-microbiological profile of chronic pulmonary aspergillosis from a tertiary care centre in Southern India",
abstract = "Background: Pulmonary aspergillosis is commonly seen in immunocompromised individuals. A significant rise has been seen in these cases in the past decade, owing to growing number of patients with impaired immune status. Aim: This study includes the detailed clinical and microbiological profiles of all the culture positive cases of pulmonary aspergillosis, detected in three years, from Jan 2008-Dec 2010, at our tertiary care centre. Methods: A hospital based observational and retrospective study was conducted to study the clinico-microbiological characteristics of patients with pulmonary aspergillosis. Respiratory specimens which showed repeated isolation of Aspergillus were included in the study. Demographic details, clinical findings and predisposing factors were noted down for all the patients. Treatment of patients with antifungal agents and their responses to treatment were also documented. Results: There were 22 patients with male to female ratio of 1.2:1 and mean age of 52.5 years. The most common underlying lung disease was presence of bronchial asthma in 27.3{\%} (6/22) cases. Many patients (40.9{\%}; 9/22) were on steroid treatment. Cough with expectoration was the most common symptom observed in 72.7{\%} (16/22) cases. Microbiologically, microscopy showed positivity for the presence of gram positive, acutely branched, fungal hyphae, suggestive of Aspergillus, in all the cases. Aspergillus fumigatus was the predominant species that was isolated in 40.9{\%} (9/22) cases. All the diagnosed patients were given either oral itraconazole or intravenous amphotericin B. A clinical improvement was observed in 72.5{\%} (16/22) cases, but 27.3{\%} (6/22) patients died. Conclusion: Pulmonary aspergillosis presents with non-specific clinical and radiological findings. An early suspicion and diagnosis is essential, especially in patients with underlying lung disease, to prevent dissemination and invasion.",
author = "Kiran Chawla and Kranthi Kosaraju and Sridevi Rayasam and Chiranjay Mukhopadhyay",
year = "2013",
month = "12",
day = "15",
doi = "10.7860/JCDR/2013/6314.3740",
language = "English",
volume = "7",
pages = "2712--2715",
journal = "Journal of Clinical and Diagnostic Research",
issn = "2249-782X",
publisher = "Journal of Clinical and Diagnostic Research",
number = "12",

}

Clinico-microbiological profile of chronic pulmonary aspergillosis from a tertiary care centre in Southern India. / Chawla, Kiran; Kosaraju, Kranthi; Rayasam, Sridevi; Mukhopadhyay, Chiranjay.

In: Journal of Clinical and Diagnostic Research, Vol. 7, No. 12, 15.12.2013, p. 2712-2715.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Clinico-microbiological profile of chronic pulmonary aspergillosis from a tertiary care centre in Southern India

AU - Chawla, Kiran

AU - Kosaraju, Kranthi

AU - Rayasam, Sridevi

AU - Mukhopadhyay, Chiranjay

PY - 2013/12/15

Y1 - 2013/12/15

N2 - Background: Pulmonary aspergillosis is commonly seen in immunocompromised individuals. A significant rise has been seen in these cases in the past decade, owing to growing number of patients with impaired immune status. Aim: This study includes the detailed clinical and microbiological profiles of all the culture positive cases of pulmonary aspergillosis, detected in three years, from Jan 2008-Dec 2010, at our tertiary care centre. Methods: A hospital based observational and retrospective study was conducted to study the clinico-microbiological characteristics of patients with pulmonary aspergillosis. Respiratory specimens which showed repeated isolation of Aspergillus were included in the study. Demographic details, clinical findings and predisposing factors were noted down for all the patients. Treatment of patients with antifungal agents and their responses to treatment were also documented. Results: There were 22 patients with male to female ratio of 1.2:1 and mean age of 52.5 years. The most common underlying lung disease was presence of bronchial asthma in 27.3% (6/22) cases. Many patients (40.9%; 9/22) were on steroid treatment. Cough with expectoration was the most common symptom observed in 72.7% (16/22) cases. Microbiologically, microscopy showed positivity for the presence of gram positive, acutely branched, fungal hyphae, suggestive of Aspergillus, in all the cases. Aspergillus fumigatus was the predominant species that was isolated in 40.9% (9/22) cases. All the diagnosed patients were given either oral itraconazole or intravenous amphotericin B. A clinical improvement was observed in 72.5% (16/22) cases, but 27.3% (6/22) patients died. Conclusion: Pulmonary aspergillosis presents with non-specific clinical and radiological findings. An early suspicion and diagnosis is essential, especially in patients with underlying lung disease, to prevent dissemination and invasion.

AB - Background: Pulmonary aspergillosis is commonly seen in immunocompromised individuals. A significant rise has been seen in these cases in the past decade, owing to growing number of patients with impaired immune status. Aim: This study includes the detailed clinical and microbiological profiles of all the culture positive cases of pulmonary aspergillosis, detected in three years, from Jan 2008-Dec 2010, at our tertiary care centre. Methods: A hospital based observational and retrospective study was conducted to study the clinico-microbiological characteristics of patients with pulmonary aspergillosis. Respiratory specimens which showed repeated isolation of Aspergillus were included in the study. Demographic details, clinical findings and predisposing factors were noted down for all the patients. Treatment of patients with antifungal agents and their responses to treatment were also documented. Results: There were 22 patients with male to female ratio of 1.2:1 and mean age of 52.5 years. The most common underlying lung disease was presence of bronchial asthma in 27.3% (6/22) cases. Many patients (40.9%; 9/22) were on steroid treatment. Cough with expectoration was the most common symptom observed in 72.7% (16/22) cases. Microbiologically, microscopy showed positivity for the presence of gram positive, acutely branched, fungal hyphae, suggestive of Aspergillus, in all the cases. Aspergillus fumigatus was the predominant species that was isolated in 40.9% (9/22) cases. All the diagnosed patients were given either oral itraconazole or intravenous amphotericin B. A clinical improvement was observed in 72.5% (16/22) cases, but 27.3% (6/22) patients died. Conclusion: Pulmonary aspergillosis presents with non-specific clinical and radiological findings. An early suspicion and diagnosis is essential, especially in patients with underlying lung disease, to prevent dissemination and invasion.

UR - http://www.scopus.com/inward/record.url?scp=84890530615&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890530615&partnerID=8YFLogxK

U2 - 10.7860/JCDR/2013/6314.3740

DO - 10.7860/JCDR/2013/6314.3740

M3 - Article

VL - 7

SP - 2712

EP - 2715

JO - Journal of Clinical and Diagnostic Research

JF - Journal of Clinical and Diagnostic Research

SN - 2249-782X

IS - 12

ER -